According to SEC filings for the period ending December 2025, BioNTech SE (NASDAQ:BNTX) is held by 266 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 5,933,594 | 480,114 | 8.80% | $564,878,131.00 |
| FLOSSBACH VON STORCH SE | 31 Dec, 2025 | 4,196,048 | -33,985 | -0.80% | $399,463,770.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Dec, 2025 | 3,800,011 | -70,755 | -1.83% | $361,761,047.00 |
| DODGE & COX | 31 Dec, 2025 | 3,614,491 | -32,600 | -0.89% | $344,099,543.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 3,086,698 | -1,746,944 | -36.14% | $293,854.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 1,596,221 | 1,099,203 | 221.16% | $151,960,239.00 |
| BNP PARIBAS FINANCIAL MARKETS | 31 Dec, 2025 | 1,578,094 | 474,796 | 43.03% | $150,234,549.00 |
| Temasek Holdings (Private) Ltd | 31 Dec, 2025 | 1,506,027 | 0 | 0.00% | $143,373,770.00 |
| BAILLIE GIFFORD & CO | 31 Dec, 2025 | 1,244,867 | -6,634,492 | -84.20% | $118,511,339.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,152,884 | 387,575 | 50.64% | $109,754,540.00 |
| Capital International Investors | 31 Dec, 2025 | 1,134,941 | -125 | -0.01% | $108,046,383.00 |
| GSK plc | 31 Dec, 2025 | 889,824 | 889,824 | 0.00% | $84,711,245.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 736,597 | 163,241 | 28.47% | $70,124,035.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 680,669 | 77,653 | 12.88% | $64,799,832.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 678,175 | 288,680 | 74.12% | $64,562,260.00 |
| Candriam S.C.A. | 31 Dec, 2025 | 604,916 | 15,464 | 2.62% | $57,590,455.00 |
| FRANKLIN RESOURCES INC | 31 Dec, 2025 | 577,900 | -154,916 | -21.14% | $55,015,819.00 |
| Long Focus Capital Management, LLC | 31 Dec, 2025 | 507,655 | 110,000 | 27.66% | $48,328,756.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 488,552 | 488,552 | 0.00% | $46,510,150.00 |
| DekaBank Deutsche Girozentrale | 31 Dec, 2025 | 481,397 | 0 | 0.00% | $46,397.00 |